Elixir Pharmaceuticals, Inc. — TTAB Proceedings
Elixir Pharmaceuticals, Inc. is a party to 9 TTAB proceedings.
Proceedings
- Proceeding 77035907 — Extensions of Time to Oppose, Terminated (filed 2007-12-13) against Amgen Inc. as defendant
- Proceeding 91180120 — Oppositions, Terminated (filed 2007-10-17) against Wyeth as defendant
- Proceeding 91179854 — Oppositions, Terminated (filed 2007-10-03) against Merck & Co., Inc. as defendant
- Proceeding 77047388 — Extensions of Time to Oppose, Terminated (filed 2007-07-11) against Wyeth as defendant
- Proceeding 77035913 — Extensions of Time to Oppose, Terminated (filed 2007-07-05) against Merck & Co., Inc. as defendant
- Proceeding 91165411 — Oppositions, Terminated (filed 2005-06-01) against NOVARTIS AG as defendant
- Proceeding 78403395 — Extensions of Time to Oppose, Terminated (filed 2005-03-02) against NOVARTIS AG as defendant
- Proceeding 78376344 — Extensions of Time to Oppose, Terminated (filed 2005-01-21) against Elixia B.V. as plaintiff
- Proceeding 91164809 — Oppositions, Terminated (filed 2005-04-01) against NBTY, INC. as defendant
Marks in These TTAB Matters
- KIRAVANCE — proceeding 77035907 (Defendant)
- NEXAVANCE — proceeding 91180120 (Defendant)
- ZENOMET — proceeding 91179854 (Defendant)
- NEXAVANCE — proceeding 77047388 (Defendant)
- ZENOMET — proceeding 77035913 (Defendant)
- NUTRACENT — proceeding 91165411 (Defendant)
- NUTRACENT — proceeding 91164809 (Defendant)
- NUTRACENT — proceeding 78403395 (Defendant)
Common TTAB Counterparties
- Merck & Co., Inc. — 2 proceedings
- NOVARTIS AG — 2 proceedings
- Wyeth — 2 proceedings
- Amgen Inc. — 1 proceedings
- Elixia B.V. — 1 proceedings
- NBTY, INC. — 1 proceedings
Recent TTAB Timeline
- 2008-02-28: 91180120 — TERMINATED involving Wyeth
- 2008-02-28: 91180120 — BOARD'S DECISION: SUSTAINED involving Wyeth
- 2008-01-26: 91179854 — TERMINATED involving Merck & Co., Inc.
- 2008-01-26: 91179854 — BOARD'S DECISION: SUSTAINED involving Merck & Co., Inc.
- 2008-01-11: 77035907 — EXTENSION OF TIME GRANTED involving Amgen Inc.
- 2008-01-11: 77035907 — INCOMING - EXT TIME TO OPPOSE FILED involving Amgen Inc.
- 2007-12-21: 91180120 — NOTICE OF DEFAULT involving Wyeth
- 2007-12-13: 77035907 — EXTENSION OF TIME GRANTED involving Amgen Inc.
- 2007-12-13: 77035907 — INCOMING - EXT TIME TO OPPOSE FILED involving Amgen Inc.
- 2007-12-04: 91179854 — NOTICE OF DEFAULT involving Merck & Co., Inc.
- 2007-10-17: 91180120 — PENDING, INSTITUTED involving Wyeth
- 2007-10-17: 91180120 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Wyeth
- 2007-10-17: 91180120 — FILED AND FEE involving Wyeth
- 2007-10-03: 91179854 — PENDING, INSTITUTED involving Merck & Co., Inc.
- 2007-10-03: 91179854 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Merck & Co., Inc.
- 2007-10-03: 91179854 — FILED AND FEE involving Merck & Co., Inc.
- 2007-07-11: 77047388 — EXTENSION OF TIME GRANTED involving Wyeth
- 2007-07-11: 77047388 — INCOMING - EXT TIME TO OPPOSE FILED involving Wyeth
- 2007-07-05: 77035913 — EXTENSION OF TIME GRANTED involving Merck & Co., Inc.
- 2007-07-05: 77035913 — INCOMING - EXT TIME TO OPPOSE FILED involving Merck & Co., Inc.
- 2006-10-24: 91165411 — TERMINATED involving NOVARTIS AG
- 2006-10-24: 91165411 — BD'S DECISION: DISMISSED W/O PREJUDICE involving NOVARTIS AG
- 2006-10-19: 91165411 — WITHDRAWAL OF OPPOSITION involving NOVARTIS AG
- 2006-10-17: 91165411 — RESPONSE DUE 30 DAYS (DUE DATE) involving NOVARTIS AG
- 2006-09-06: 91165411 — SUBMITTED ON BRIEF involving NOVARTIS AG
- 2006-08-01: 91164809 — BD'S DECISION: DISMISSED W/ PREJUDICE involving NBTY, INC.
- 2006-04-12: 91164809 — TERMINATED involving NBTY, INC.
- 2006-04-12: 91164809 — BD'S DECISION: DISMISSED W/O PREJUDICE involving NBTY, INC.
- 2006-02-21: 91164809 — MOT TO AMEND APPLICATION involving NBTY, INC.
- 2005-12-15: 91165411 — SUSPENDED involving NOVARTIS AG